9.81 USD
+0.16 (+1.66%)
9.83 USD
+0.02 (+0.2%)
ChartMill assigns a Buy % Consensus number of 83% to CRMD. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 19.38. This target is 97.55% above the current price.
CRMD was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CRMD.
In the previous month the buy percentage consensus was at a similar level.
CRMD was analyzed by 13 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-11-12 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-11-12 | Needham | Maintains | Buy -> Buy |
| 2025-10-21 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-20 | D. Boral Capital | Upgrade | Hold -> Buy |
| 2025-09-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-06-30 | D. Boral Capital | Downgrade | Buy -> Hold |
| 2025-06-30 | HC Wainwright & Co. | Initiate | Buy |
| 2025-06-24 | Needham | Maintains | Buy -> Buy |
| 2025-06-23 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-06-20 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-05-07 | Needham | Maintains | Buy -> Buy |
| 2025-05-06 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-04-08 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-26 | Needham | Maintains | Buy -> Buy |
| 2025-03-26 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-03-25 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-03-07 | Leerink Partners | Initiate | Outperform |
| 2025-03-05 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-22 | D. Boral Capital | Maintains | Buy -> Buy |
| 2025-01-13 | D. Boral Capital | Initiate | Buy |
| 2024-12-19 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-10-31 | Needham | Maintains | Buy -> Buy |
| 2024-10-22 | Truist Securities | Maintains | Buy -> Buy |
| 2024-08-26 | Rodman & Renshaw | Initiate | Buy |
| 2024-08-15 | Needham | Reiterate | Buy -> Buy |
| 2024-08-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-07-25 | Truist Securities | Maintains | Buy -> Buy |
CORMEDIX INC / CRMD FAQ
What is the price target for CRMD stock?
13 analysts have analysed CRMD and the average price target is 19.38 USD. This implies a price increase of 97.55% is expected in the next year compared to the current price of 9.81.
What is the consensus rating for CORMEDIX INC (CRMD) stock?
The consensus rating for CORMEDIX INC (CRMD) is 83.0769 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed CORMEDIX INC (CRMD)?
The number of analysts covering CORMEDIX INC (CRMD) is 13.